Earnings results
Quarterly results as US companies announce them to the SEC (Form 8-K, Item 2.02), with figures from each company’s own filed statements. About half of companies file detailed figures the same day they announce; the rest show as pending until the quarterly statement arrives. No analyst estimates, no consensus: what was reported, compared with the same quarter a year earlier.
10,776 announcements in the last 12 months · page 79 of 108
| Announced | Company | Period | Revenue | Rev YoY | Net income | EPS | EPS YoY | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-03-05 | ContextLogic Holdings Inc. (LOGC) | Q4 FY2025 | — | — | $-13.0M | -0.49 | — | 8-K |
| 2026-03-05 | Lexicon Pharmaceuticals, Inc. (LXRX) | Q4 FY2025 | $5.5M | 254.4% | $-15.5M | -0.04 | — | 8-K |
| 2026-03-05 | Methode Electronics Inc. (MEI) | Q3 FY2026 | $233.7M | -2.6% | $-15.9M | -0.45 | — | 8-K |
| 2026-03-05 | Metagenomi Therapeutics, Inc. (MGX) | Q4 FY2025 | $3.9M | -59.3% | $-22.5M | -0.60 | — | 8-K |
| 2026-03-05 | Marvell Technology, Inc. (MRVL) | Q4 FY2026 | $2.22B | 22.1% | $396.1M | 0.46 | 97.0% | 8-K |
| 2026-03-05 | Myers Industries Inc. (MYE) | Q4 FY2025 | $204.0M | 0.0% | $11.3M | 0.30 | 164.6% | 8-K |
| 2026-03-05 | NewLake Capital Partners, Inc. (NLCP) | Q4 FY2025 | $10.8M | -4.4% | $6.0M | 0.29 | -0.0% | 8-K |
| 2026-03-05 | Nutex Health Inc. (NUTX) | Q4 FY2025 | $151.7M | -41.1% | $11.8M | 1.74 | -80.2% | 8-K |
| 2026-03-05 | Quanex Building Products CORP (NX) | Q1 FY2026 | $409.1M | 2.3% | $-4.1M | -0.09 | — | 8-K |
| 2026-03-05 | Olaplex Holdings, Inc. (OLPX) | Q4 FY2025 | $105.1M | 4.3% | $-13.1M | -0.02 | — | 8-K |
| 2026-03-05 | Orion Properties Inc. (ONL) | Q4 FY2025 | $35.2M | -8.2% | $-35.8M | -0.64 | — | 8-K |
| 2026-03-05 | OptimizeRx Corp (OPRX) | Q4 FY2025 | $32.2M | -0.2% | $5.0M | 0.27 | — | 8-K |
| 2026-03-05 | Owlet, Inc. (OWLT) | Q4 FY2025 | — | — | $-9.1M | — | — | 8-K |
| 2026-03-05 | Ranpak Holdings Corp. (PACK) | Q4 FY2025 | $93.7M | 2.3% | $-9.5M | -0.11 | — | 8-K |
| 2026-03-05 | Profound Medical Corp. (PROF) | Q4 FY2025 | $6.7M | 66.8% | $-8.2M | -0.27 | — | 8-K |
| 2026-03-05 | CarParts.com, Inc. (PRTS) | Q4 FY2025 | $120.4M | — | $-11.6M | -0.19 | — | 8-K |
| 2026-03-05 | Pattern Group Inc. (PTRN) | Q4 FY2025 | $723.1M | 40.3% | $28.7M | 0.16 | — | 8-K |
| 2026-03-05 | Rand Capital Corp. (RAND) | Q4 FY2025 | — | — | $1.1M | 0.37 | — | 8-K |
| 2026-03-05 | Red Violet, Inc. (RDVT) | Q4 FY2025 | $23.4M | 19.6% | $2.8M | 0.20 | 224.7% | 8-K |
| 2026-03-05 | Ring Energy, Inc. (REI) | Q4 FY2025 | $66.9M | -19.8% | $-12.8M | -0.06 | -319.9% | 8-K |
| 2026-03-05 | REGENXBIO Inc. (RGNX) | Q4 FY2025 | $30.3M | 43.0% | $-67.1M | -1.30 | — | 8-K |
| 2026-03-05 | Ranger Energy Services, Inc. (RNGR) | Q4 FY2025 | $142.2M | -0.6% | $3.2M | 0.14 | -44.6% | 8-K |
| 2026-03-05 | Sandridge Energy Inc. (SD) | Q4 FY2025 | $39.4M | 1.1% | $21.6M | 0.58 | 23.8% | 8-K |
| 2026-03-05 | Seaport Entertainment Group Inc. (SEG) | Q4 FY2025 | $29.5M | 30.4% | $-36.9M | -2.89 | — | 8-K |
| 2026-03-05 | Silence Therapeutics plc (SLN) | Q4 FY2025 | $34,000 | -99.9% | $-11.8M | -0.08 | -195.6% | 8-K |
| 2026-03-05 | Smith & Wesson Brands, Inc. (SWBI) | Q3 FY2026 | $135.7M | 17.1% | $3.8M | 0.08 | 60.0% | 8-K |
| 2026-03-05 | Teads Holding Co. (TEAD) | Q4 FY2025 | $352.2M | 50.2% | $-428.2M | -4.48 | — | 8-K |
| 2026-03-05 | TriSalus Life Sciences, Inc. (TLSI) | Q4 FY2025 | $13.2M | 59.8% | $-9.8M | -0.21 | — | 8-K |
| 2026-03-05 | Toro Co. (TTC) | Q1 FY2026 | $1.04B | 4.2% | $67.9M | 0.69 | 32.7% | 8-K |
| 2026-03-05reported in filing | Via Renewables, Inc. (VIASP) | Q4 FY2025 | $127.8M | 22.5% | $6.9M | 1.81 | -39.4% | 8-K |
| 2026-03-05 | Vulcan Infrastructure & Power Inc. (VIP) | Q4 FY2025 | $11.5M | -22.6% | $3.0M | 0.19 | — | 8-K |
| 2026-03-04 | ACRES Commercial Realty Corp. (ACR) | Q4 FY2025 | $20.0M | -6.5% | — | -0.39 | -175.0% | 8-K |
| 2026-03-04 | Advanced Flower Capital Inc. (AFCG) | Q4 FY2025 | $5.2M | -32.1% | $914,046 | 0.04 | — | 8-K |
| 2026-03-04 | Alto Ingredients, Inc. (ALTO) | Q4 FY2025 | $232.0M | -1.9% | $21.8M | 0.27 | — | 8-K |
| 2026-03-04 | Ardent Health, Inc. (ARDT) | Q4 FY2025 | $1.61B | -0.1% | $45.0M | 0.32 | -61.0% | 8-K |
| 2026-03-04 | Altisource Portfolio Solutions S.A. (ASPS) | Q4 FY2025 | $42.3M | 3.2% | $-7.1M | -0.62 | — | 8-K |
| 2026-03-04 | Broadcom Inc. (AVGO) | Q1 FY2026 | $19.31B | 29.5% | $7.35B | 1.50 | 31.6% | 8-K |
| 2026-03-04 | Aware Inc. (AWRE) | Q4 FY2025 | $4.7M | -2.8% | $-1.5M | -0.07 | — | 8-K |
| 2026-03-04 | Bath & Body Works, Inc. (BBWI) | Q4 FY2025 | $2.72B | -2.3% | $403.0M | 1.99 | -5.8% | 8-K |
| 2026-03-04 | Brown Forman Corp. (BF.B) | Q3 FY2026 | $1.06B | 2.0% | $267.0M | 0.58 | 1.8% | 8-K |
| 2026-03-04reported in filing | Biolargo, Inc. (BLGO) | Q4 FY2025 | $617,000 | -83.1% | — | — | — | 8-K |
| 2026-03-04 | BillionToOne, Inc. (BLLN) | Announced; detailed figures pending the quarterly statement | 8-K | |||||
| 2026-03-04 | Babcock & Wilcox Enterprises, Inc. (BW) | Q4 FY2025 | $138.8M | 2.0% | $9.2M | 0.08 | — | 8-K |
| 2026-03-04 | Bowman Consulting Group Ltd. (BWMN) | Q4 FY2025 | $129.0M | 13.9% | $2.0M | 0.12 | -64.5% | 8-K |
| 2026-03-04 | Cracker Barrel Old Country Store, Inc. (CBRL) | Q2 FY2026 | $874.8M | -7.9% | $1.3M | 0.06 | -93.9% | 8-K |
| 2026-03-04 | Cross Country Healthcare Inc. (CCRN) | Q4 FY2025 | $236.8M | -23.6% | $-82.9M | -2.56 | — | 8-K |
| 2026-03-04 | Cardlytics, Inc. (CDLX) | Q4 FY2025 | $50.9M | -25.5% | $-8.3M | -0.15 | — | 8-K |
| 2026-03-04 | ChargePoint Holdings, Inc. (CHPT) | Q4 FY2026 | $109.3M | 7.3% | $-44.4M | -1.85 | — | 8-K |
| 2026-03-04 | Compx International Inc. (CIX) | Q4 FY2025 | $37.7M | -1.9% | $4.7M | 0.38 | 3.6% | 8-K |
| 2026-03-04 | Cps Technologies Corp. (CPSH) | Q4 FY2025 | $8.2M | 38.3% | $12,595 | 0.00 | — | 8-K |
| 2026-03-04 | Daktronics Inc. (DAKT) | Q3 FY2026 | $181.9M | 21.6% | $3.0M | 0.06 | — | 8-K |
| 2026-03-04 | Duos Technologies Group, Inc. (DUOT) | Q4 FY2025 | $9.5M | 547.5% | $-3.2M | -0.16 | — | 8-K |
| 2026-03-04 | EyePoint, Inc. (EYPT) | Announced; detailed figures pending the quarterly statement | 8-K | |||||
| 2026-03-04 | Hudson Technologies Inc. (HDSN) | Q4 FY2025 | $44.4M | 28.2% | $-8.6M | -0.19 | — | 8-K |
| 2026-03-04 | Holley Inc. (HLLY) | Q4 FY2025 | $155.4M | 11.0% | $6.3M | 0.05 | — | 8-K |
| 2026-03-04 | Immucell Corp. (ICCC) | Announced; detailed figures pending the quarterly statement | 8-K | |||||
| 2026-03-04 | IEH Corp (IEHC) | Q3 FY2026 | $7.5M | 3.9% | $-660,286 | -0.27 | — | 8-K |
| 2026-03-04 | Intrepid Potash, Inc. (IPI) | Q4 FY2025 | — | — | $-429,000 | -0.03 | — | 8-K |
| 2026-03-04 | Keros Therapeutics, Inc. (KROS) | Q4 FY2025 | $188,000 | -93.8% | $-23.5M | -0.84 | — | 8-K |
| 2026-03-04 | Pulmonx Corp (LUNG) | Q4 FY2025 | $22.6M | -4.9% | $-10.4M | -0.25 | — | 8-K |
| 2026-03-04 | Mistras Group, Inc. (MG) | Q4 FY2025 | $181.5M | 5.1% | $3.9M | 0.12 | -26.3% | 8-K |
| 2026-03-04 | Miller Industries Inc. (MLR) | Q4 FY2025 | $171.9M | -22.5% | $3.4M | 0.30 | -67.4% | 8-K |
| 2026-03-04 | MAGNACHIP SEMICONDUCTOR Corp (MX) | Q4 FY2025 | $40.6M | -20.7% | $-8.1M | -0.22 | — | 8-K |
| 2026-03-04 | Niagen Bioscience, Inc. (NAGE) | Q4 FY2025 | $33.8M | 16.2% | $4.1M | 0.05 | -44.6% | 8-K |
| 2026-03-04 | Nacco Industries Inc. (NC) | Q4 FY2025 | $66.8M | -5.2% | $-3.8M | -0.51 | -150.0% | 8-K |
| 2026-03-04 | NCS Multistage Holdings, Inc. (NCSM) | Q4 FY2025 | $50.6M | 12.5% | $15.0M | 5.35 | 307.9% | 8-K |
| 2026-03-04 | Nn Inc. (NNBR) | Q4 FY2025 | $104.7M | -1.7% | $-12.5M | -0.25 | — | 8-K |
| 2026-03-04 | National Presto Industries Inc. (NPK) | Q4 FY2025 | $164.0M | 21.7% | $15.0M | — | — | 8-K |
| 2026-03-04 | OmniAb, Inc. (OABIW) | Q4 FY2025 | $8.4M | -22.5% | $-14.2M | -0.11 | — | 8-K |
| 2026-03-04 | Omega Flex, Inc. (OFLX) | Q4 FY2025 | $25.2M | -6.5% | $3.4M | 0.34 | -27.1% | 8-K |
| 2026-03-04 | Okta, Inc. (OKTA) | Q4 FY2026 | $761.0M | 11.6% | $63.0M | 0.35 | 192.1% | 8-K |
| 2026-03-04 | Orion Group Holdings Inc (ORN) | Q4 FY2025 | $233.2M | 7.5% | $-240,000 | -0.01 | -103.5% | 8-K |
| 2026-03-04 | Park Ohio Holdings Corp. (PKOH) | Q4 FY2025 | $395.0M | 1.7% | $1.0M | 0.07 | 100.8% | 8-K |
| 2026-03-04 | Preformed Line Products Co. (PLPC) | Q4 FY2025 | $173.1M | 3.6% | $8.4M | 1.72 | -19.4% | 8-K |
| 2026-03-04 | Riley Exploration Permian, Inc. (REPX) | Q4 FY2025 | $97.3M | -5.3% | $85.4M | 4.02 | 680.1% | 8-K |
| 2026-03-04 | Republic Airways Holdings Inc. (RJET) | Q4 FY2025 | $1.07B | 934.7% | $128.1M | 3.37 | — | 8-K |
| 2026-03-04reported in filing | Scynexis Inc. (SCYX) | Q4 FY2025 | — | — | $12.3M | 0.24 | — | 8-K |
| 2026-03-04 | SES AI Corp (SES) | Q4 FY2025 | $4.6M | — | $-17.0M | -0.05 | — | 8-K |
| 2026-03-04 | Stabilis Solutions, Inc. (SLNG) | Q4 FY2025 | $13.3M | -23.3% | $-262,000 | -0.01 | -112.4% | 8-K |
| 2026-03-04 | SmartRent, Inc. (SMRT) | Q4 FY2025 | $36.5M | 3.1% | $-3.2M | -0.02 | — | 8-K |
| 2026-03-04 | Smith Micro Software, Inc. (SMSI) | Q4 FY2025 | $4.0M | -20.0% | $-4.6M | -0.19 | — | 8-K |
| 2026-03-04 | Stem, Inc. (STEM) | Q4 FY2025 | $47.1M | -15.6% | $-16.0M | -1.86 | — | 8-K |
| 2026-03-04 | Latham Group, Inc. (SWIM) | Q4 FY2025 | $100.0M | 14.5% | $-7.0M | -0.06 | — | 8-K |
| 2026-03-04 | TScan Therapeutics, Inc. (TCRX) | Q4 FY2025 | $2.6M | 286.0% | $-23.0M | -0.18 | — | 8-K |
| 2026-03-04 | TriplePoint Venture Growth BDC Corp. (TPVG) | Q4 FY2025 | — | — | $8.1M | 0.20 | — | 8-K |
| 2026-03-04 | Veeva Systems Inc. (VEEV) | Q4 FY2026 | $836.0M | 16.0% | $244.2M | 1.49 | 26.5% | 8-K |
| 2026-03-04reported in filing | Village Super Market Inc. (VLGEA) | Q2 FY2026 | $641.0M | 6.9% | $17.9M | — | — | 8-K |
| 2026-03-04 | Viemed Healthcare, Inc. (VMD) | Q4 FY2025 | $76.2M | 25.5% | $5.6M | 0.14 | 34.1% | 8-K |
| 2026-03-03 | Ascent Industries Co. (ACNT) | Q4 FY2025 | $18.8M | 3.5% | $-1.0M | -0.11 | — | 8-K |
| 2026-03-03 | Amylyx Pharmaceuticals, Inc. (AMLX) | Q4 FY2025 | — | — | $-33.0M | -0.30 | — | 8-K |
| 2026-03-03 | Arcturus Therapeutics Holdings Inc. (ARCT) | Q4 FY2025 | $7.2M | -68.4% | $-29.1M | -1.03 | — | 8-K |
| 2026-03-03 | Autozone Inc. (AZO) | Q2 FY2026 | $4.27B | 8.1% | $468.9M | 27.63 | -2.3% | 8-K |
| 2026-03-03 | Best Buy Co. Inc. (BBY) | Q4 FY2026 | $13.81B | -1.0% | $541.0M | 2.57 | 372.3% | 8-K |
| 2026-03-03 | Cumberland Pharmaceuticals Inc. (CPIX) | Q4 FY2025 | $13.7M | 31.1% | $-1.4M | -0.10 | — | 8-K |
| 2026-03-03 | Cricut, Inc. (CRCT) | Q4 FY2025 | $203.6M | -2.7% | $7.8M | 0.03 | -37.6% | 8-K |
| 2026-03-03 | CrowdStrike Holdings, Inc. (CRWD) | Q4 FY2026 | $1.31B | 23.3% | $59.4M | 0.24 | — | 8-K |
| 2026-03-03 | Civeo Corp (CVEO) | Q4 FY2025 | $161.6M | 7.1% | $-6.5M | -0.56 | — | 8-K |
| 2026-03-03 | Cryoport, Inc. (CYRX) | Q4 FY2025 | $45.5M | 9.6% | $-11.6M | -0.23 | — | 8-K |
| 2026-03-03 | Eastern Co. (EML) | Q4 FY2026 | — | — | $1.2M | — | — | 8-K |
| 2026-03-03 | Evolus, Inc. (EOLS) | Announced; detailed figures pending the quarterly statement | 8-K | |||||
Source: SEC EDGAR. Figures are as reported in each company’s filings and may be unaudited or restated; a company that announces results in more than one filing (for example a delivery report and an earnings release) appears once per filing. Most rows come from an earnings release (Form 8-K, Item 2.02). Some companies file no separate release, so their periodic report is the event and the row is marked “reported in filing”. Foreign private issuers appear only where their Form 6-K tags the financial data itself, which is a minority of them: many report half-yearly, so there is no quarter to show and they are left out rather than listed without figures. Informational only. Not investment advice.